Martin Currie’s AbbVie ABBV Stock Holding History

Martin Currie’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,500	Closed	-$532K	–	106
2017 Q4	$532K	Hold	5,500	–	–	0.04%	91
2017 Q3	$489K	Hold	5,500	–	–	0.04%	83
2017 Q2	$399K	Sell	5,500 -72,850	-93%	-$4.9M	0.03%	89
2017 Q1	$5.11M	Sell	78,350 -6,600	-8%	-$415K	0.42%	62
2016 Q4	$5.32M	Sell	84,950 -3,900	-4%	-$238K	0.5%	58
2016 Q3	$5.6M	Sell	88,850 -5,000	-5%	-$324K	0.51%	55
2016 Q2	$5.81M	Sell	93,850 -164,050	-64%	-$10M	0.56%	53
2016 Q1	$14.7M	Sell	257,900 -8,700	-3%	-$485K	1.4%	25
2015 Q4	$15.8M	Sell	266,600 -5,600	-2%	-$323K	1.6%	21
2015 Q3	$14.8M	Buy	272,200 +4,850	+2%	+$316K	1.53%	21
2015 Q2	$18M	Buy	267,350 +34,800	+15%	+$2.27M	1.72%	20
2015 Q1	$13.6M	Sell	232,550 -265,700	-53%	-$16.1M	1.22%	30
2014 Q4	$32.6M	Sell	498,250 -197,050	-28%	-$12.4M	2.8%	9
2014 Q3	$40.2M	Sell	695,300 -61,600	-8%	-$3.42M	3.45%	6
2014 Q2	$42.7M	Sell	756,900 -19,200	-2%	-$1.01M	3.7%	4
2014 Q1	$39.9M	Sell	776,100 -35,800	-4%	-$1.81M	3.66%	6
2013 Q4	$42.9M	Buy	811,900 +60,100	+8%	+$2.95M	3.94%	4
2013 Q3	$33.6M	Buy	751,800 +35,900	+5%	+$1.59M	3.61%	5
2013 Q2	$29.6M	Buy	+715,900	New	+$31.3M	3.22%	6

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Martin Currie's ABBV Position: Q1 2018 in Review

Martin Currie sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 5,500 shares — an estimated $532K sold.

Martin Currie first reported a position in ABBV in Q2 2013 and held it in 19 quarters. The position peaked at $42.9M in Q4 2013. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Martin Currie reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Martin Currie sold 5,500 AbbVie shares in Q1 2018, an estimated $532K.
Martin Currie first reported a position in AbbVie in Q2 2013 and held it in 19 quarters.
Martin Currie's AbbVie position peaked at $42.9M in Q4 2013.
2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Martin Currie's 13F filing for Q1 2018, filed 15 May 2018.